Health biotechnology innovation on a global stage

Nature Reviews Microbiology

Volumn 9, Issue 2, 2011, Pages 137-143

  Thorsteinsdóttir, Halla ^a   Ray, Monali ^b   Kapoor, Andrew ^b   Daar, Abdallah S ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BIOTECHNOLOGY; CLINICAL TRIAL (TOPIC); DEVELOPING COUNTRY; GLOBAL CHANGE; HEALTH CARE ORGANIZATION; HEALTH ECONOMICS; HEALTH PROGRAM; MEDICAL RESEARCH; PATENT; PRIORITY JOURNAL;

BIOTECHNOLOGY; HUMANS; INTERNATIONAL COOPERATION; RESEARCH; WORLD HEALTH;

EID: 78651499008     PISSN: 17401526     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrmicro2492     Document Type: Article

References (35)

1. Zur Hausen, H. Papillomaviruses and cancer: from basic studies to clinical application. Nature Rev. Cancer 2, 342-350 (2002).
2. Nugent, R. Chronic diseases in developing countries. Ann. NY Acad. Sci. 1136, 70-79 (2008).
3. Yach, D., Hawkes, C., Gould, C. L. & Hofman, K. J. The global burden of chronic diseases: overcoming impediments to prevention and control. JAMA 291, 2616-2622 (2004).
4. Thorsteinsdóttir, H. et al. South-South entrepreneurial collaboration in health biotech. Nature Biotech. 28, 407-416 (2010).
5. Velho, L. North-South collaboration and systems of innovation. Int. J. Tech. Manag. Sustain. Dev. 1, 171-181 (2002).
6. Gaillard, J. F. North-South research partnership: is collaboration possible between unequal partners- Knowl. Technol. Policy 7, 31-63 (1994).
7. Salomon, J. J., Sagasti, F. & Sachs, C. (eds) The Uncertain Quest: Science, Technology, and Development (United Nations Univ. Press, Tokyo, 2000).
8. Sagasti, F. R. Knowledge and Innovation for Development: The Sisyphus Challenge of the 21st Century (Edward Elgar, Cheltenham, 2004).
9. Blickenstaff, J. & Moravcsik, M. J. Scientific output in the third-world. Scientometrics 4, 135-169 (1982).
10. Jasanoff, S. et al. (eds) Handbook of Science and Technology Studies (SagePublications, Thousand Oaks, 1995).
11. Shrum, W. & Campion, P. Are scientists in developing countries isolated- Sci. Technol. Soc. 5, 1-34 (2000).
12. Sim, A. & Ali, Y. Performance of international joint ventures from developing and developed countries: an empirical study in a developing country context. J. World Bus. 33, 357-377 (1998).
13. Powell, W. W., Koput, K. W. & Smith-Doerr, L. Interorganizational collaboration and the locus of innovation: networks of learning in biotechnology. Adm. Sci. Q. 41, 116-145 (1996).
14. Ray, M., Daar, A. S., Singer, P. A. & Thorsteinsdóttir, H. Globetrotting firms: Canada's health biotechnology collaborations with developing countries. Nature Biotech. 27, 806-814 (2009).
15. Motari, M. et al. South Africa - blazing a trail for African biotechnology. Nature Biotech. 22, DC37-DC41 (2004).
16. Hardy, B.-J. et al. The next steps for genomic medicine: challenges and opportunities for the developing world. Nature Rev. Gen. 9, S23-S27 (2008).
17. Villa, L. L. et al. Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. N. Engl. J. Med. 356, 1915-1927 (2007).
18. Thiers, F. A., Sinskey, A. J. & Berndt, E. R. Trends in the globalization of clinical trials. Nature Rev. Drug Discov. 7, 13-14 (2008).
19. Reveiz, L. et al. The Latin American ongoing clinical trial register (LATINREC). Rev. Panam. Salud Pública 19, 417-422 (2006).
20. Thorsteinsdottir, H., Quach, U., Martin, D. K., Daar, A. S. & Singer, P. A. Introduction: promoting global health through biotechnology. Nature Biotech. 22, DC3-DC7 (2004).
21. Thorsteinsdottir, H., Quach, U., Daar, A. S. & Singer, P. A. Conclusions: promoting biotechnology innovation in developing countries. Nature Biotech. 22, DC48-DC52 (2004).
22. Kumar, N. K. et al. Indian biotechnology - rapidly evoling and industry led. Nature Biotech. 22, DC31-DC36 (2004).
23. Li, Z. Z. et al. Health biotechnology in China - reawakening of a giant. Nature. Biotech. 22, DC13-DC18 (2004).
24. Mokoena, R. South-South co-operation: The case for IBSA. S. Afr. J. Int. Affairs 14, 125-145 (2007).
25. Africa-India Forum. Africa-India Framework for Cooperation, 2008 Africa-India Forum Summit [online] http://www.africa-union.org/root/UA/ Conferences/2008/avril/BCP/India Summit 04-09avr/ INDE - AFRIQUE SITE/AFRICA-INDIA FRAMEWORK FOR COOPERATION ENGLISH - FINAL VERSION.doc (2008).
26. Kenyon, G. China offers billions in loans to boost health research in Africa. Nature Med. 16, 8 (2010).
27. Government of the Peoples Republic of China. Chinese Scholarship Council Annual Report 2007 (Beijing, 2007).
28. Kigotho, W. Kenyans protest at being left off AIDS patent. Nature 408, 6 (2000).
29. Lundvall, B. Å. National Systems of Innovation: Towards a Theory of Innovation and Interactive Learning (Pinter, London, 1992).
30. Kraemer-Mbula, E. & Wamae, W. (eds) Innovation and the Development Agenda (Organisation for Economic Co-operation and Development & the International Development Research Centre, Canada, 2010).
31. Frew, S. E. et al. India's health biotech sector at a crossroads. Nature Biotech. 25, 403-417 (2007).
32. Rezaie, R. et al. Brazilian health biotech - fostering crosstalk between public and private sectors. Nature Biotech. 26, 627-644 (2008).
33. Clifford, G. M. et al. Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet 366, 991-998 (2005).
34. Villa, L. L. et al. Prophylactic quadrivalent human papillomavirus (types 6, 11, 16 and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncol. 6, 271-278 (2005).
35. Lal, B. et al. Inhibitors of cyclin-dependent kinases and their use. US Patent 7271193 (2007).